Reproductive Health
Contraception as part of comprehensive, individualized gender-affirming care.
Overview
EURA provides contraceptive care via telemedicine for all patients who need it — regardless of how they identify or what hormones they are taking. Eura prescribes all contraceptive options that can be safely managed remotely, and discusses how each option fits your individual goals, including menstrual suppression where relevant.
Important: Gender-affirming hormones — including testosterone — are not reliable contraception. Even if your periods have stopped on testosterone, ovulation can still occur. If pregnancy is a possibility you want to avoid, dedicated contraception is recommended.
A good option for patients on testosterone or those who cannot use estrogen-containing contraceptives. Taken daily at the same time each day.
Can help reduce or stop periods over time and is compatible with masculinizing hormone therapy.
Highly effective when taken consistently. May not be appropriate for all patients — Ted will review your health history and hormone regimen before prescribing.
Not typically recommended alongside feminizing hormone therapy or for patients with certain cardiovascular risk factors.
A patch worn on the skin, changed weekly for three weeks with one patch-free week. Similar efficacy and considerations to the combined pill.
Same estrogen-related considerations apply. Ted will discuss whether this is appropriate for your situation.
Inserted vaginally and worn for three weeks, then removed for one week. Offers the same hormonal profile as combined pills with less daily management.
May not be preferred by all patients. Ted will talk through comfort and fit for your goals.
A progestin-only injection given every 12 weeks. Eura writes the prescription — you receive the injection at a pharmacy or local clinic.
Frequently leads to menstrual cessation and is compatible with testosterone therapy. A strong option if daily adherence is a concern.
Plan B and generic equivalents are available over the counter. For patients who need a prescription-strength option or guidance on timing and efficacy, Eura can assist via telemedicine.
Effectiveness decreases with time — should be used as soon as possible after unprotected sex.
The following require a procedural visit and cannot be provided via telemedicine. Eura is happy to refer you to an affirming provider for these:
For Patients on Testosterone
For many transmasculine and non-binary patients, stopping periods is an important part of care. While testosterone often reduces or eliminates menstruation over time, this is not guaranteed — and some patients prefer a dedicated contraceptive option to achieve suppression more reliably or more quickly.
Common Questions
Yes. Progestin-only options — including the mini-pill and Depo-Provera — are safe and commonly used alongside testosterone therapy. Ted will review your full health history to identify the best fit.
Potentially yes. The absence of periods does not confirm that ovulation has stopped. If there is any possibility of pregnancy and you want to prevent it, a dedicated contraceptive method is recommended regardless of your cycle status.
Depo-Provera has the highest rate of menstrual cessation among the options Eura prescribes. The progestin-only pill is also effective for many patients. The right choice depends on your goals, current medications, and preferences — Ted will go through this with you at your visit.
Not directly — IUD insertion and implant placement require an in-person procedure. Eura can refer you to an affirming provider for these and support your care before and after if needed.
Progestin-only methods generally do not interfere with testosterone therapy. Estrogen-containing methods require more careful consideration and are evaluated case by case. Eura will never prescribe something that conflicts with your affirming care goals without discussing it first.
Clinical References
Transgender-specific reproductive health guidance on this page — including the relationship between testosterone and fertility, progestin-only contraception in transmasculine patients, and menstrual suppression — is informed by:
[1] Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. World Professional Association for Transgender Health (WPATH), 2022.
[2] Deutsch MB, ed. Guidelines for the Primary and Affirmative Care of Transgender and Gender Nonbinary People, 2nd ed. UCSF Transgender Care, 2016.
General contraceptive method descriptions reflect standard clinical pharmacology and prescribing practice.
Schedule a visit to discuss your contraceptive options and how they fit your goals.